← Back to Search

Morning Bright Light Therapy for TBI

Led By Miranda M Lim, MD, PhD
Research Sponsored by Portland VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
History of macular degeneration
Decisionally impaired
Screening 3 weeks
Treatment Varies
Follow Up baseline; after 4 weeks of intervention; and 2 months after the end of intervention
Awards & highlights


This trial aims to determine the effect of morning bright light therapy on sleep quality in veterans with traumatic brain injury.

Who is the study for?
This trial is for Veterans who have experienced traumatic brain injury or stress disorders and are having trouble with their sleep. It's not suitable for those who don't speak English, have macular degeneration, decision-making impairments, bipolar disorder, or are already using light therapy.Check my eligibility
What is being tested?
The study tests if Morning Bright Light Therapy (MBLT) can improve sleep quality in Veterans with traumatic brain injuries. Participants will use MBLT daily for 4 weeks and their sleep patterns will be monitored before, during, and three months after the therapy.See study design
What are the potential side effects?
While the description doesn't specify side effects of MBLT, common ones may include eyestrain, headache or nausea. However, it's generally considered safe with minimal risks when used appropriately.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
I have a history of macular degeneration.
I am unable to make my own medical decisions.
I do not speak English.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; after 4 weeks of intervention; and 2 months after the end of intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; after 4 weeks of intervention; and 2 months after the end of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Insomnia Severity Index (ISI)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Morning Bright Light TherapyExperimental Treatment1 Intervention
Subjects who engage in morning bight light therapy
Group II: ControlActive Control1 Intervention
Subjects who do not engage in morning bright light therapy

Find a Location

Who is running the clinical trial?

Portland VA Medical CenterLead Sponsor
42 Previous Clinical Trials
7,826 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
985 Previous Clinical Trials
7,385,524 Total Patients Enrolled
Miranda M Lim, MD, PhDPrincipal Investigator - Portland VA Medical Center
Portland VA Medical Center
1 Previous Clinical Trials
300 Total Patients Enrolled

Media Library

Morning Bright Light Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03578003 — N/A
Traumatic Brain Injury Research Study Groups: Morning Bright Light Therapy, Control
Traumatic Brain Injury Clinical Trial 2023: Morning Bright Light Therapy Highlights & Side Effects. Trial Name: NCT03578003 — N/A
Morning Bright Light Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03578003 — N/A
~0 spots leftby Aug 2024